Markus Keiser
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 25
- Drug Transport and Resistance Mechanisms 23
-
- Pharmacological Effects and Toxicity Studies 12
- Co-authors
- Stefan Oswald (21 shared papers)Werner Siegmund (18 shared papers)Markus Grube (7 shared papers)Werner Weitschies (5 shared papers)Jens‐Peter Kühn (3 shared papers)Heyo K. Kroemer (3 shared papers)Hassan Y. Naim (6 shared papers)Janett Müller (3 shared papers)
In The Last Decade
Markus Keiser
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 100
- Oncology 609
- Hepatology 158
- Pharmacology 186
- Pediatrics, Perinatology and Child Health 303
- Biochemistry 70
Countries citing papers authored by Markus Keiser
This map shows the geographic impact of Markus Keiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Keiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Keiser more than expected).
Fields of papers citing papers by Markus Keiser
This network shows the impact of papers produced by Markus Keiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Keiser. The network helps show where Markus Keiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Keiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 206 | |
| 2 | 2010 | 120 | |
| 3 | 2012 | 119 | |
| 4 | 2016 | 88 | |
| 5 | 2012 | 61 | |
| 6 | 2008 | 55 | |
| 7 | 2017 | 53 | |
| 8 | 2012 | 49 | |
| 9 | 2005 | 46 | |
| 10 | 2013 | 43 | |
| 11 | 2015 | 40 | |
| 12 | 2011 | 40 | |
| 13 | 2017 | 36 | |
| 14 | 2012 | 34 | |
| 15 | 2014 | 29 | |
| 16 | 2013 | 26 | |
| 17 | 2016 | 26 | |
| 18 | 2018 | 25 | |
| 19 | 2014 | 25 | |
| 20 | 2006 | 24 |
About Markus Keiser
Markus Keiser is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Pharmacology, Genetics and Infectious Diseases, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Pharmacological Effects and Toxicity Studies (12 papers), Pharmacogenetics and Drug Metabolism (6 papers), Digestive system and related health (5 papers), Metabolism and Genetic Disorders (3 papers), Amino Acid Enzymes and Metabolism (3 papers), HIV/AIDS drug development and treatment (3 papers) and Pregnancy and Medication Impact (3 papers). The work is most often cited by research in Oncology (609 citations), Hepatology (158 citations), Pharmacology (186 citations), Pediatrics, Perinatology and Child Health (303 citations) and Biochemistry (70 citations). Markus Keiser has collaborated with scholars based in Germany, Sweden and Poland. Frequent co-authors include Stefan Oswald, Werner Siegmund, Markus Grube, Werner Weitschies, Jens‐Peter Kühn, Heyo K. Kroemer, Hassan Y. Naim, Janett Müller, Martin F. Fromm and Hartmut Glaeser. Their work appears in journals such as Molecular Pharmaceutics, Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Gastroenterology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.